supply of medicinal items (anti- cancer drugs) on two years rate contract basis for cnci both the campuses supply of medicinal items (anti- cancer drugs) on two years rate contract basis for cnci both the campuses , inj carfilzomib- 30mg , inj carfilzomib- 60mg , inj peg l-asparaginase-3750u , tab venetoclax- 20mg , tab venetoclax- 400mg , tab venetoclax- 600mg , inj vinorelbine- 10mg , inj vinorelbine- 30mg , inj azacytidine- 100mg , tab ibrutinib- 140mg , inj darbapoetin alfa-200mcg , inj darbapoetin alfa-500mcg , inj romiplostim – 250mcg , inj romiplostim – 500mcg , inj romiplostim – 125 mcg , tab eltrombopag-25mg , tab eltrombopag-50mg , tab dasatinib- 50mg , tab dasatinib- 70mg , tab bosutinib- 400mg , tab bosutinib- 500mg , tab midostaurin-25mg , inj inotuzumab ozogamicin- 1mg , inj decitabine- 20mg , inj decitabine- 50mg , inj methotrexate -15mg , inj methotrexate -500mg , inj methotrexate -1gm , tab azacytidine- 200mg , tab azacytidine- 300mg , tab thalidomide-50mg , tab thalidomide-100mg , inj cytarabine- 1g , tab atra-10mg , inj arsenic trioxide- 10mg , tab cabozantanib 40mg , inj octreotide depot 30mg , tab lapatinib 200mg , tab sunitinib 12.5mg , ing eribulin 1mg , ing vinorelbine 10mg , ing.degarelix 180mg , ing.degarelix 120mg , tdm,(ado trastuzumab)100 mg , tdm,(ado trastuzumab)160mg , onco bcg 40mg , ing plerixafor 24mg , tab pazopanib 200 mg , tab pazopanib 400 mg , inj cabazitaxel 60 mg , tab capecitabine /cyclophosphamide700 mg/30 , tab capecitabine /cyclophosphamide400 mg/20 , inj docetaxel rtu 20 mg , inj docetaxel rtu 120mg , inj gemcitabine 1200ml rtu , inj gemcitabine 1400 ml rtu , inj rasburicase 1.5 mg , tab afatanib 20 mg , tab afatanib 30 mg , tab afatanib 40 mg